Upgrade to SI Premium - Free Trial

BTIG Starts bluebird bio (BLUE) at Buy

March 1, 2016 7:02 AM
BTIG initiated coverage on bluebird bio (NASDAQ: BLUE) with a Buy rating and a price target of $72.00.Analyst Dane Leone ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View New Coverage

Next Articles